News
55mon MSN
Chrissy Metz Warns About The 'Slippery Slope' Of Ozempic Use After Her 100-Pound Weight Loss
Chrissy Metz has opened up about her health journey, sharing her nuanced views on weight loss drugs such as Ozempic.
A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results